Quantitative prediction of radiographic progression in patients with axial spondyloarthritis using neural network model in a real-world setting

被引:6
|
作者
Baek, In-Woon [1 ]
Jung, Seung Min [2 ]
Park, Yune-Jung [2 ]
Park, Kyung-Su [2 ]
Kim, Ki-Jo [2 ]
机构
[1] Ewha Womans Univ, Coll Med, Div Rheumatol, Dept Internal Med, Seoul, South Korea
[2] Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Internal Med, 93 Jungbu Daero, Suwon 16247, Gyeonggi, South Korea
关键词
Axial spondyloarthritis; Radiographic progression; Artificial neural network; Quantitative prediction; Real-world setting; ANKYLOSING-SPONDYLITIS; SYNDESMOPHYTES; CLASSIFICATION; VALIDATION; CRITERIA; DAMAGE;
D O I
10.1186/s13075-023-03050-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundPredicting radiographic progression in axial spondyloarthritis (axSpA) remains limited because of the complex interaction between multiple associated factors and individual variability in real-world settings. Hence, we tested the feasibility of artificial neural network (ANN) models to predict radiographic progression in axSpA.MethodsIn total, 555 patients with axSpA were split into training and testing datasets at a 3:1 ratio. A generalized linear model (GLM) and ANN models were fitted based on the baseline clinical characteristics and treatment-dependent variables for the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) of the radiographs at follow-up time points. The mSASSS prediction was evaluated, and explainable machine learning methods were used to provide insights into the model outcome or prediction.ResultsThe R-2 values of the fitted models were in the range of 0.90-0.95 and ANN with an input of mSASSS as the number of each score performed better (root mean squared error (RMSE) = 2.83) than GLM or input of mSASSS as a total score (RMSE = 2.99-3.57). The ANN also effectively captured complex interactions among variables and their contributions to the transition of mSASSS over time in the fitted models. Structural changes constituting the mSASSS scoring systems were the most important contributing factors, and no detectable structural abnormalities at baseline were the most significant factors suppressing mSASSS change.ConclusionsClinical and radiographic data-driven ANN allows precise mSASSS prediction in real-world settings. Correct evaluation and prediction of spinal structural changes could be beneficial for monitoring patients with axSpA and developing a treatment plan.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Secukinumab Retention and Effectiveness in Patients with Psoriatic Arthritis and Radiographic Axial Spondyloarthritis: 5-year Final Results of a Prospective Real-world Study
    Kiltz, Uta
    Sfikakis, Petros
    Bounas, Andreas
    Gullick, Nicola
    Lespessailles, Eric
    Juergens, Jan Brandt
    Rashkov, Rasho
    Schulz, Barbara
    Bao, Weibin
    Jagiello, Piotr
    Gaffney, Karl
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4725 - 4727
  • [22] Real-world evidence for secukinumab in UK patients with psoriatic arthritis or radiographic axial spondyloarthritis: interim 2-year analysis from SERENA
    Gaffney, Karl
    Gullick, Nicola
    Mackay, Kirsten
    Patel, Yusuf
    Sengupta, Raj
    Sheeran, Tom
    Hemmings, Louise
    Pamies, Paula
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2023, 7 (03)
  • [23] Patients with Axial Spondyloarthritis Are at Risk of Developing Adhesive Capsulitis: Real-World Evidence Database Study in Taiwan
    Huang, Shih-Wei
    Wang, Jr-Yi
    Lin, Che-Li
    Huang, Chi-Chang
    Liou, Tsan-Hon
    Lin, Hui-Wen
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (03)
  • [24] Treatment Decision Making Among Axial Spondyloarthritis Patients: Real-World Data from the ArthritisPower Registry
    Nowell, William
    Hunter, Theresa
    Gavigan, Kelly
    Curtis, Jeffrey R.
    Malatestinic, William
    Bolce, Rebecca
    Lisse, Jeffrey
    Kronbergs, Andris
    Himelein, Carol
    Walker, Jennifer
    Walsh, Jessica
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [25] Clinical performance of ASAS Health Index in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: real-world evidence from Multicenter Nationwide Registry
    Ozgur Akgul
    Hatice Bodur
    Sebnem Ataman
    Fatma Gul Yurdakul
    Erhan Capkin
    Gulcan Gurer
    Ilhan Sezer
    Mehmet Tuncay Duruoz
    Meltem Alkan Melikoglu
    Hasan Fatih Cay
    Aylin Rezvani
    Ilker Yagci
    Feride Gogus
    Ayhan Kamanli
    Remzi Cevik
    Rheumatology International, 2020, 40 : 1793 - 1801
  • [26] Clinical performance of ASAS Health Index in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: real-world evidence from Multicenter Nationwide Registry
    Akgul, Ozgur
    Bodur, Hatice
    Ataman, Sebnem
    Yurdakul, Fatma Gul
    Capkin, Erhan
    Gurer, Gulcan
    Sezer, Ilhan
    Duruoz, Mehmet Tuncay
    Melikoglu, Meltem Alkan
    Cay, Hasan Fatih
    Rezvani, Aylin
    Yagci, Ilker
    Gogus, Feride
    Kamanli, Ayhan
    Cevik, Remzi
    RHEUMATOLOGY INTERNATIONAL, 2020, 40 (11) : 1793 - 1801
  • [27] Four-year secukinumab treatment outcomes in European real-world patients with axial spondyloarthritis and psoriatic arthritis
    Pons, Marion
    Georgiadis, Stylianos
    Ostergaard, Mikkel
    Ahmadzay, Zohra Faizy
    Glintborg, Bente
    Heberg, Jette
    Christensen, Sara Nysom
    Rasmussen, Simon
    Loft, Anne Gitte
    Castrejon, Isabel
    Sanchez-Alonso, Fernando
    Iannone, Florenzo
    Nordstrom, Dan
    Hokkanen, Anna-Mari
    Ciurea, Adrian
    Nissen, Michael J.
    Zavada, Jakub
    Pavelka, Karel
    Rotar, Ziga
    Pirkmajer, Katja Perdan
    Michelsen, Brigitte
    Mielnik, Pawel
    Bernardes, Miguel
    Khmelinskii, Nikita
    Laas, Karin
    Vorobjov, Sigrid
    Codreanu, Catalin
    Macfarlane, Gary J.
    Jones, Gareth T.
    Gudbjornsson, Bjorn
    Palsson, Olafur
    Wallman, Johan K.
    van der Horst-bruinsma, Irene
    Onen, Fatos
    Hetland, Merete Lund
    Ornbjerg, Lykke Midtboll
    JOINT BONE SPINE, 2025, 92 (03)
  • [28] DISEASE TRAJECTORIES OF AXIAL SPONDYLOARTHRITIS PATIENTS INITIATED ON BIOLOGIC DMARDS: PRELIMINARY ANALYSIS FROM A REAL-WORLD COHORT
    Barnett, R.
    Carpenter, L.
    Cavill, C.
    Sengupta, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 769 - 770
  • [29] GO-BEYOND: a real-world study of persistence of golimumab in patients with axial spondyloarthritis and rheumatoid arthritis in Turkey
    Akar, Servet
    Kalyoncu, Umut
    Dalkilic, Ediz
    Emmungil, Hakan
    Aziz, Ayten
    Esen, Yasemin
    Koc, Tuba
    IMMUNOTHERAPY, 2021, 13 (10) : 841 - 850
  • [30] GO-BEYOND: A REAL-WORLD PERSISTENCE STUDY WITH GOLIMUMAB IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS AND RHEUMATOID ARTHRITIS IN TURKEY
    Akar, Servet
    Kalyoncu, Umut
    Dalkili, Ediz
    Emmungil, Hakan
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 2159 - 2160